PHOTOBIOMODULATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Takeaways from Analyst

Rising prevalence of dermatological and musculoskeletal disorders worldwide will be a key driver boosting the demand for photobiomodulation therapies. Furthermore, increasing adoption of non-invasive procedures and growing geriatric population susceptible to various age-related conditions will propel the market forward.

However, lack of reimbursement policies for photobiomodulation treatments especially in developing nations may impede market potential in the short-run. Moreover, high costs associated with laser and light therapy devices could restrict market growth to some extent.

The Asia Pacific region excluding Japan is anticipated to emerge as the fastest growing regional market due to rising medical tourism, fast economic development, and improving access to healthcare in countries like China and India. North America will likely continue dominating the global market supported by advanced healthcare infrastructure and investments in research and development. Latin America and the Middle East & Africa also offer promising growth opportunities for photobiomodulation manufacturers.